Your browser doesn't support javascript.
loading
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
Horne, Hisani N; Chung, Charles C; Zhang, Han; Yu, Kai; Prokunina-Olsson, Ludmila; Michailidou, Kyriaki; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Hopper, John L; Southey, Melissa C; Schmidt, Marjanka K; Broeks, Annegien; Muir, Kenneth; Lophatananon, Artitaya; Fasching, Peter A; Beckmann, Matthias W; Fletcher, Olivia; Johnson, Nichola; Sawyer, Elinor J; Tomlinson, Ian; Burwinkel, Barbara; Marme, Frederik; Guénel, Pascal; Truong, Thérèse; Bojesen, Stig E; Flyger, Henrik; Benitez, Javier; González-Neira, Anna; Anton-Culver, Hoda; Neuhausen, Susan L; Brenner, Hermann; Arndt, Volker; Meindl, Alfons; Schmutzler, Rita K; Brauch, Hiltrud; Hamann, Ute; Nevanlinna, Heli; Khan, Sofia; Matsuo, Keitaro; Iwata, Hiroji; Dörk, Thilo; Bogdanova, Natalia V; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Chenevix-Trench, Georgia; Wu, Anna H; Ven den Berg, David.
Afiliação
  • Horne HN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
  • Chung CC; Food and Drug Administration, Silver Spring, MD, United States of America.
  • Zhang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
  • Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
  • Prokunina-Olsson L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
  • Michailidou K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Hopper JL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Southey MC; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Schmidt MK; Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Muir K; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
  • Fasching PA; Institute of Population Health, University of Manchester, Manchester, UK.
  • Beckmann MW; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
  • Fletcher O; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Johnson N; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, United States of America.
  • Sawyer EJ; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Tomlinson I; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Burwinkel B; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  • Marme F; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Guénel P; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  • Truong T; Research Oncology, Guy's Hospital, King's College London, London, UK.
  • Bojesen SE; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Flyger H; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Benitez J; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • González-Neira A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Anton-Culver H; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Neuhausen SL; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.
  • Brenner H; University Paris-Sud, Villejuif, France.
  • Arndt V; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.
  • Meindl A; University Paris-Sud, Villejuif, France.
  • Schmutzler RK; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brauch H; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Hamann U; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Nevanlinna H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Khan S; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Matsuo K; Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain.
  • Iwata H; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Dörk T; Department of Epidemiology, University of California Irvine, Irvine, CA, United States of America.
  • Bogdanova NV; Beckman Research Institute of City of Hope, Duarte, CA, United States of America.
  • Lindblom A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Margolin S; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mannermaa A; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kosma VM; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chenevix-Trench G; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
  • Wu AH; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
  • Ven den Berg D; Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.
PLoS One ; 11(8): e0160316, 2016.
Article em En | MEDLINE | ID: mdl-27556229
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Neoplasias da Mama / Mapeamento Cromossômico / Locos de Características Quantitativas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 1 / Neoplasias da Mama / Mapeamento Cromossômico / Locos de Características Quantitativas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article